MedPath

ARGENX US, INC.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
https://www.argenx.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

FDA:2

Drug Approvals

VYVGART Hytrulo

Approval Date
Jan 23, 2024
FDA

VYVGART

Approval Date
Jan 23, 2024
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.